NAVELLIER & ASSOCIATES INC - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 195 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.

Quarter-by-quarter ownership
NAVELLIER & ASSOCIATES INC ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$1,860,000
+74.6%
106,862
+68.7%
0.41%
+60.5%
Q2 2020$1,065,000
-40.6%
63,344
-44.5%
0.25%
+1.2%
Q2 2018$1,793,000
-2.8%
114,041
+1.7%
0.25%
-10.7%
Q1 2018$1,844,000
+1.4%
112,090
+11.3%
0.28%
-17.6%
Q4 2017$1,819,000
+144.2%
100,738
+161.1%
0.34%
+134.5%
Q3 2017$745,00038,5800.14%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,003,723$95,164,0006.41%
TANAKA CAPITAL MANAGEMENT INC 65,609$780,0003.41%
S&T BANK/PA 588,620$6,999,0001.93%
Parallel Advisors, LLC 1,405,895$16,716,0001.35%
Matarin Capital Management, LLC 623,915$7,418,0001.15%
AJ WEALTH STRATEGIES, LLC 668,020$7,943,0001.08%
Capital Impact Advisors, LLC 177,300$2,108,0000.88%
Alambic Investment Management, L.P. 29,547$351,0000.85%
OXFORD FINANCIAL GROUP, LTD. LLC 332,436$3,953,0000.79%
Spark Investment Management LLC 116,400$1,383,0000.74%
View complete list of CORCEPT THERAPEUTICS INC shareholders